Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction

NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway. Variants in this gene have been described to cause a multisystem disease characterized by neuromotor impairment, neuropathy, intellectual disability, and dysmorphic features. Here, we describe four patients with pathogenic variants in NGLY1. As the clinical features and laboratory results of the patients suggested a multisystem mitochondrial disease, a muscle biopsy had been performed. Biochemical analysis in muscle showed a strongly reduced ATP production rate in all patients, while individual OXPHOS enzyme activities varied from normal to reduced. No causative variants in any mitochondrial disease genes were found using mtDNA analysis and whole exome sequencing. In all four patients, variants in NGLY1 were identified, including two unreported variants (c.849T>G (p.(Cys283Trp)) and c.1067A>G (p.(Glu356Gly)). Western blot analysis of N-glycanase in muscle and fibroblasts showed a complete absence of N-glycanase. One patient showed a decreased basal and maximal oxygen consumption rates in fibroblasts. Mitochondrial morphofunction fibroblast analysis showed patient specific differences when compared to control cell lines. In conclusion, variants in NGLY1 affect mitochondrial energy metabolism which in turn might contribute to the clinical disease course.

Saved in:
Bibliographic Details
Main Authors: Panneman, Daan M., Wortmann, Saskia B., Haaxma, Charlotte A., van Hasselt, Peter M., Wolf, Nicole I., Hendriks, Yvonne, Küsters, Benno, van Emst-de Vries, Sjenet, van de Westerlo, Els, Koopman, Werner J.H., Wintjes, Liesbeth, van den Brandt, Frans, de Vries, Maaike, Lefeber, Dirk J., Smeitink, Jan A.M., Rodenburg, Richard J.
Format: Article/Letter to editor biblioteca
Language:English
Subjects:NGLY1, OXPHOS enzyme activity, Seahorse respirometry, Whole exome sequencing, mitochondrial disorders,
Online Access:https://research.wur.nl/en/publications/variants-in-ngly1-lead-to-intellectual-disability-myoclonus-epile
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-623227
record_format koha
spelling dig-wur-nl-wurpubs-6232272025-01-15 Panneman, Daan M. Wortmann, Saskia B. Haaxma, Charlotte A. van Hasselt, Peter M. Wolf, Nicole I. Hendriks, Yvonne Küsters, Benno van Emst-de Vries, Sjenet van de Westerlo, Els Koopman, Werner J.H. Wintjes, Liesbeth van den Brandt, Frans de Vries, Maaike Lefeber, Dirk J. Smeitink, Jan A.M. Rodenburg, Richard J. Article/Letter to editor Clinical Genetics 97 (2020) 4 ISSN: 0009-9163 Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction 2020 NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway. Variants in this gene have been described to cause a multisystem disease characterized by neuromotor impairment, neuropathy, intellectual disability, and dysmorphic features. Here, we describe four patients with pathogenic variants in NGLY1. As the clinical features and laboratory results of the patients suggested a multisystem mitochondrial disease, a muscle biopsy had been performed. Biochemical analysis in muscle showed a strongly reduced ATP production rate in all patients, while individual OXPHOS enzyme activities varied from normal to reduced. No causative variants in any mitochondrial disease genes were found using mtDNA analysis and whole exome sequencing. In all four patients, variants in NGLY1 were identified, including two unreported variants (c.849T>G (p.(Cys283Trp)) and c.1067A>G (p.(Glu356Gly)). Western blot analysis of N-glycanase in muscle and fibroblasts showed a complete absence of N-glycanase. One patient showed a decreased basal and maximal oxygen consumption rates in fibroblasts. Mitochondrial morphofunction fibroblast analysis showed patient specific differences when compared to control cell lines. In conclusion, variants in NGLY1 affect mitochondrial energy metabolism which in turn might contribute to the clinical disease course. en text/html https://research.wur.nl/en/publications/variants-in-ngly1-lead-to-intellectual-disability-myoclonus-epile 10.1111/cge.13706 https://edepot.wur.nl/644907 NGLY1 OXPHOS enzyme activity Seahorse respirometry Whole exome sequencing mitochondrial disorders https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic NGLY1
OXPHOS enzyme activity
Seahorse respirometry
Whole exome sequencing
mitochondrial disorders
NGLY1
OXPHOS enzyme activity
Seahorse respirometry
Whole exome sequencing
mitochondrial disorders
spellingShingle NGLY1
OXPHOS enzyme activity
Seahorse respirometry
Whole exome sequencing
mitochondrial disorders
NGLY1
OXPHOS enzyme activity
Seahorse respirometry
Whole exome sequencing
mitochondrial disorders
Panneman, Daan M.
Wortmann, Saskia B.
Haaxma, Charlotte A.
van Hasselt, Peter M.
Wolf, Nicole I.
Hendriks, Yvonne
Küsters, Benno
van Emst-de Vries, Sjenet
van de Westerlo, Els
Koopman, Werner J.H.
Wintjes, Liesbeth
van den Brandt, Frans
de Vries, Maaike
Lefeber, Dirk J.
Smeitink, Jan A.M.
Rodenburg, Richard J.
Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
description NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway. Variants in this gene have been described to cause a multisystem disease characterized by neuromotor impairment, neuropathy, intellectual disability, and dysmorphic features. Here, we describe four patients with pathogenic variants in NGLY1. As the clinical features and laboratory results of the patients suggested a multisystem mitochondrial disease, a muscle biopsy had been performed. Biochemical analysis in muscle showed a strongly reduced ATP production rate in all patients, while individual OXPHOS enzyme activities varied from normal to reduced. No causative variants in any mitochondrial disease genes were found using mtDNA analysis and whole exome sequencing. In all four patients, variants in NGLY1 were identified, including two unreported variants (c.849T>G (p.(Cys283Trp)) and c.1067A>G (p.(Glu356Gly)). Western blot analysis of N-glycanase in muscle and fibroblasts showed a complete absence of N-glycanase. One patient showed a decreased basal and maximal oxygen consumption rates in fibroblasts. Mitochondrial morphofunction fibroblast analysis showed patient specific differences when compared to control cell lines. In conclusion, variants in NGLY1 affect mitochondrial energy metabolism which in turn might contribute to the clinical disease course.
format Article/Letter to editor
topic_facet NGLY1
OXPHOS enzyme activity
Seahorse respirometry
Whole exome sequencing
mitochondrial disorders
author Panneman, Daan M.
Wortmann, Saskia B.
Haaxma, Charlotte A.
van Hasselt, Peter M.
Wolf, Nicole I.
Hendriks, Yvonne
Küsters, Benno
van Emst-de Vries, Sjenet
van de Westerlo, Els
Koopman, Werner J.H.
Wintjes, Liesbeth
van den Brandt, Frans
de Vries, Maaike
Lefeber, Dirk J.
Smeitink, Jan A.M.
Rodenburg, Richard J.
author_facet Panneman, Daan M.
Wortmann, Saskia B.
Haaxma, Charlotte A.
van Hasselt, Peter M.
Wolf, Nicole I.
Hendriks, Yvonne
Küsters, Benno
van Emst-de Vries, Sjenet
van de Westerlo, Els
Koopman, Werner J.H.
Wintjes, Liesbeth
van den Brandt, Frans
de Vries, Maaike
Lefeber, Dirk J.
Smeitink, Jan A.M.
Rodenburg, Richard J.
author_sort Panneman, Daan M.
title Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
title_short Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
title_full Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
title_fullStr Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
title_full_unstemmed Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
title_sort variants in ngly1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
url https://research.wur.nl/en/publications/variants-in-ngly1-lead-to-intellectual-disability-myoclonus-epile
work_keys_str_mv AT pannemandaanm variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT wortmannsaskiab variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT haaxmacharlottea variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT vanhasseltpeterm variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT wolfnicolei variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT hendriksyvonne variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT kustersbenno variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT vanemstdevriessjenet variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT vandewesterloels variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT koopmanwernerjh variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT wintjesliesbeth variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT vandenbrandtfrans variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT devriesmaaike variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT lefeberdirkj variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT smeitinkjanam variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
AT rodenburgrichardj variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction
_version_ 1822267134915379200